Piper Sandler Reiterates Overweight on Glaukos, Maintains $165 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 82.4%

Neg 0% Neu 82.4% Pos 0%

Piper Sandler analyst Adam Maeder reiterates Glaukos (NYSE:GKOS) with a Overweight and maintains $165 price target.

Comments

No comments yet. Be the first!